首页> 外国专利> PHARMACEUTICAL ORAL, ENTERAL OR BY-INHALATION DOSAGE FORM FOR SUPPRESSING AN AUTOIMMUNE RESPONSE ASSOCIATED WITH TYPE I DIABETES

PHARMACEUTICAL ORAL, ENTERAL OR BY-INHALATION DOSAGE FORM FOR SUPPRESSING AN AUTOIMMUNE RESPONSE ASSOCIATED WITH TYPE I DIABETES

机译:抑制与I型糖尿病有关的自身免疫反应的口服,肠内或吸入式药物制剂

摘要

Disclosed herein are methods for treating or preventing a disease in mammals having the characteristics of Type 1 diabetes comprising administering insulin or disease suppressive fragments of insulin or analogs thereof in oral or aerosol dosage forms to said mammals. Also disclosed herein are pharmaceutical formulation or dosage forms for use in the methods.
机译:本文公开了用于治疗或预防具有1型糖尿病特征的哺乳动物的疾病的方法,包括以口服或气雾剂形式向所述哺乳动物施用胰岛素或胰岛素或其类似物的疾病抑制片段。本文还公开了用于所述方法的药物制剂或剂型。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号